Substrain-specific differences in survival and osteonecrosis incidence in a mouse model

Comparative Medicine

Volumn 62, Issue 6, 2012, Pages 466-471

  Kawedia, Jitesh D ^a,c   Janke, Laura ^a   Funk, Amy J ^a   Ramsey, Laura B ^a   Liu, Chengcheng ^a   Jenkins, David ^a   Boyd, KelliL ^b   Relling, Mary V ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE NECROSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; INCIDENCE; LOADING DRUG DOSE; LOW DRUG DOSE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PERINATAL PERIOD;

ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; MICE, INBRED BALB C; OSTEONECROSIS; SPECIES SPECIFICITY; SURVIVAL ANALYSIS;

EID: 84876252843     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Eisenstein TK, Meissler JJ Jr, Rogers TJ, Geller EB, Adler MW. 1995. Mouse strain differences in immunosuppression by opioids in vitro. J Pharmacol Exp Ther 275:1484-1489. (Pubitemid 26129940)
2. Giant TT, Bardos T, Vermes C, Chandrasekaran R, Valdez JC, Otto JM, Gerard D, Velins S, Lovasz G, Zhang J, Mikecz K, Finnegan A. 2001. Variations in susceptibility to proteoglycan-induced arthritis and spondylitis among C3H substrains of mice: evidence of genetically acquired resistance to autoimmune disease. Arthritis Rheum 44:682-692. (Pubitemid 32234628)
3. Graham ML, Janecek JL, Kittredge JA, Hering BJ, Schuurman HJ. 2011. The streptozotocin-induced diabetic nude mouse model: differences between animals from different sources. Comp Med 61:356-360.
4. Henricks KK, Miner LL, Marley RJ. 1997. Differential cocaine sensitivity between 2 closely related substrains of C57BL mice. Psychopharmacology (Berl) 132:161-168. (Pubitemid 27338991)
5. Ito T, Takahashi M, Sudo K, Sugiyama Y. 2007. Marked strain differences in the pharmacokinetics of an α4β1 integrin antagonist, 4-[1-[3-chloro-4-[N-(2-methylphenyl)-ureido]phenylacetyl]-(4S)-fluoro-(2S) -pyrrolidine-2-yl]-methoxybenzoic acid (D01-4582), in Sprague-Dawley rats are associated with albumin genetic polymorphism. J Pharmacol Exp Ther 320:124-132. (Pubitemid 46025727)
6. Kawedia JD, Kaste SC, Pei D, Panetta JC, Cai X, Cheng C, Neale G, Howard SC, Evans WE, Pui CH, Relling MV. 2011. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood 117:2340-2347.
7. Marks MJ, Romm E, Gaffney DK, Collins AC. 1986. Nicotine-induced tolerance and receptor changes in 4 mouse strains. J Pharmacol Exp Ther 237:809-819. (Pubitemid 16088097)
8. Nicholson SM, Peterson JD, Miller SD, Wang K, Dal Canto MC, Melvold RW. 1994. BALB/c substrain differences in susceptibility to Theiler murine encephalomyelitis virus-induced demyelinating disease. J Neuroimmunol 52:19-24. (Pubitemid 24182241)
9. Ralph RJ, Paulus MP, Geyer MA. 2001. Strain-specific effects of amphetamine on prepulse inhibition and patterns of locomotor behavior in mice. J Pharmacol Exp Ther 298:148-155. (Pubitemid 32574521)
10. Sekirov I, Finlay BB. 2009. The role of the intestinal microbiota in enteric infection. J Physiol 587:4159-4167.
11. Silvia OJ, Urosevic N. 1999. Variations in LPS responsiveness among different mouse substrains of C3H lineage and their congenic derivative sublines. Immunogenetics 50:354-357.
12. Teuscher C, Hickey WF, Korngold R. 1990. Experimental allergic orchitis in mice. V. Resistance to actively induced disease in BALB/cJ substrain mice is mediated by CD4+ T cells. Immunogenetics 32:34-40. (Pubitemid 20228210)
13. Yang L, Boyd K, Kaste SC, Kamdem Kamdem L, Rahija RJ, Relling MV. 2009. A mouse model for glucocorticoid-induced osteonecrosis: effect of a steroid holiday. J Orthop Res 27:169-175.